Nitric oxide inhibits the expression of AT 1 receptors in neurons

American Journal of Physiology - Cell Physiology

Volumn 302, Issue 8, 2012, Pages

  Sharma, Neeru M ^a   Zheng, Hong ^a   Li, Yi Fan ^b   Patel, Kaushik P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Angiotensin II; cGMP; Protein kinase G; Sympathetic nerve activity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; DEFEROXAMINE; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; NERVE CELL; NEUROBLASTOMA CELL; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ADENOVIRIDAE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CALCIUM; CELL LINE, TUMOR; CELLS, CULTURED; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DNA, ANTISENSE; HYPOTHALAMUS; NEURONS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE I; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; S-NITROSO-N-ACETYLPENICILLAMINE; TRANSFECTION;

RATTUS;

EID: 84859784422     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00258.2011     Document Type: Article

References (55)

1. Azizi M, Menard J. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation 109: 2492-2499, 2004.
2. Bains JS, Ferguson AV. Angiotensin II neurotransmitter actions in paraventricular nucleus are potentiated by a nitric oxide synthase inhibitor. Regul Pept 50: 53-59, 1994.
3. Cahill PA, Redmond EM, Poster C, Sitzmann JV. Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells. Eur J Pharmacol 288: 219-229, 1995.
4. Channon KM, Blazing MA, Shetty GA, Potts KE, George SE. Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc Res 32: 962-972, 1996.
5. Christopherson KS, Hillier BJ, Lim WA, Bredt DS. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 274: 27467-27473, 1999.
6. Consolim-Colombo FM, Hay M, Smith TC, Elizondo-Fournier M, Bishop VS. Supcellular mechanisms of angiotensin II and arginine vasopressin activation of area postrema neurons. Am J Physiol Regul Integr Comp Physiol 271: R34-R41, 1996.
7. Contestabile A. Regulation of transcription factors by nitric oxide in neurons and in neural-derived tumor cells. Prog Neurobiol 84: 317-328, 2008.
8. Deslauriers B, Ponce C, Lombard C, Larguier R, Bonnafous JC, Marie J. N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane. Biochem J 339: 397-405, 1999.
9. Fernandez SF, Huang MH, Davidson BA, Knight PR 3rd, Izzo JL Jr. Modulation of angiotensin II responses in sympathetic neurons by cytosolic calcium. Hypertension 41: 56-63, 2003.
10. Fishman MC, Zimmerman EA, Slater EE. Renin and angiotensin: the complete system within the neuroblastoma × glioma cell. Science 214: 921-923, 1981.
11. Gebke E, Muller AR, Jurzak M, Gerstberger R. Angiotensin II-induced calcium signalling in neurons and astrocytes of rat circumventricular organs. Neuroscience 85: 509-520, 1998.
12. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation 87: 1816-1828, 1993.
13. Hamprecht B. Structural, electrophysiological, biochemical, and pharmacological properties of neuroblastoma-glioma cell hybrids in cell culture. Int Rev Cytol 49: 99-170, 1977.
14. Hanafy KA, Krumenacker JS, Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit 7: 801-819, 2001.
15. Harrison-Bernard LM, Imig JD, Carmines PK. Renal AT1 receptor protein expression during the early stage of diabetes mellitus. Int J Exp Diabetes Res 3: 97-108, 2002.
16. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 18: 195-199, 1993.
17. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 31: 342-348, 1998.
18. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41: 485-490, 1991.
19. Kinugawa T, Ogino K, kitamura H, Saitoh M, Omodani H, Osaki S, Hisatome I, Miyakoda H. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during supmaximal exercise in patients with congestive heart failure. Am J Med Sci 312: 110-117, 1996.
20. Kleiber AC, Zheng H, Schultz HD, Peuler JD, Patel KP. Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure. Am J Physiol Regul Integr Comp Physiol 294: R1863-R1872, 2008.
21. 1 expression within the PVN in rats with heart failure. Am J Physiol Heart Circ Physiol 298: H1546-H1555, 2010.
22. Krukoff TL. Central regulation of autonomic function: no brakes? Clin Exp Pharmacol Physiol 25: 474-478, 1998.
23. Kumagai K, Reid IA. Angiotensin II exerts differential actions on renal nerve activity and heart rate. Hypertension 24: 451-456, 1994.
24. Laflamme L, Brechler V, Reudelhuber TL, Gallo-Payet N, Deschepper CF. The renin-angiotensin system in hybrid NG108-15 cells. Renin gene is from mouse neuroblastoma, angiotensinogen and angiotensinconverting enzyme genes are of rat glioma origin. Regul Pept 77: 9-15, 1998.
25. Leclerc PC, Lanctot PM, Auger-Messier M, Escher E, Leduc R, Guillemette G. S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II. Br J Pharmacol 148: 306-313, 2006.
26. Lenkei Z, Corvol P, Llorens-Cortes C. The angiotensin receptor suptype AT1A predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control. Brain Res Mol Brain Res 30: 53-60, 1995.
27. Li DP, Chen SR, Pan HL. Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. J Neurosci 23: 5041-5049, 2003.
28. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: altered inhibitory mechanisms. Acta Physiol Scand 177: 17-26, 2003.
29. Li YF, Wang W, Mayhan WG, Patel KP. Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Regul Integr Comp Physiol 290: R1035-R1043, 2006.
30. Li YF, Wang Y, Channon KM, Schultz HD, Zucker IH, Patel KP. Manipulation of neuronal nitric oxide synthase within the paraventricular nucleus using adenovirus and antisense technology. Methods Mol Med 112: 59-79, 2005.
31. Liu JL, Murakami H, Zucker IH. Angiotensin II nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ Res 82: 496-502, 1998.
32. Madhusoodanan KS, Murad F. NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem Res 32: 681-694, 2007.
33. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97, 2007.
34. 1 receptor expression: sequential activation of NF-κB and Elk-1 in neurons. Am J Physiol Cell Physiol 299: C561-C569, 2010.
35. Myers J. Effects of exercise training on abnormal ventilatory responses to exercise in patients with chronic heart failure. Congest Heart Fail 6: 243-249, 2000.
36. Parekh N, Dobrowolski L, Zou AP, Steinhausen M. Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney. Am J Physiol Regul Integr Comp Physiol 270: R630-R635, 1996.
37. Patzak A, Mrowka R, Storch E, Hocher B, Persson PB. Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 12: 1122-1127, 2001.
38. Pfister J, Spengler C, Grouzmann E, Raizada MK, Felix D, Imboden H. Intracellular staining of angiotensin receptors in the PVN and SON of the rat. Brain Res 754: 307-310, 1997.
39. Qian H, Pipolo L, Thomas WG. Association of beta-arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization. Mol Endocrinol 15: 1706-1719, 2001.
40. Sharma NM, Zheng H, Mehta PP, Li YF, Patel KP. Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II. Cardiovasc Res 92: 348-57, 2011.
41. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276: 2034-2037, 1997.
42. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 89: 444-448, 1992.
43. 1 receptor signalling pathways in neurons. Clin Exp Pharmacol Physiol 29: 483-490, 2002.
44. Tallant EA, Diz DI, Khosla MC, Ferrario CM. Identification and regulation of angiotensin II receptor suptypes on NG108-15 cells. Hypertension 17: 1135-1143, 1991.
45. Thomas WG, Motel TJ, Kule CE, Karoor V, Baker KM. Phosphorylation of the angiotensin II (AT1A) receptor carboxyl terminus: a role in receptor endocytosis. Mol Endocrinol 12: 1513-1524, 1998.
46. Usui M, Ichiki T, Katoh M, Egashira K, Takeshita A. Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland. Hypertension 32: 527-533, 1998.
47. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, Iadecola C. NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 24: 5516-5524, 2004.
48. Wang WH. The cGMP-dependent protein kinase stimulates the basolateral 18-pS K channel of the rat CCD. Am J Physiol Cell Physiol 278: C1212-C1217, 2000.
49. Wassmann S, Nickenig G. The role of AT1 receptor in the cardiovascular continuum. Eur Heart J Suppl 6: H3-H9, 2004.
50. Yang RF, Yin JX, Li YL, Zimmerman MC, Schultz HD. Angiotensin- (1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism. Am J Physiol Cell Physiol 300: C58-C64, 2011.
51. Zhang ZH, Francis J, Weiss RM, Felder RB. The renin-angiotensinaldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol 283: H423-H433, 2002.
52. Zheng H, Li YF, Wang W, Patel KP. Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure. Am J Physiol Regul Integr Comp Physiol 297: R1364-R1374, 2009.
53. Zheng H, Liu X, Li Y, Sharma NM, Patel KP. Gene transfer of neuronal nitric oxide synthase to the paraventricular nucleus reduces the enhanced glutamatergic tone in rats with chronic heart failure. Hypertension;58: 966-973, 2011.
54. Zheng H, Liu X, Patel KP. Angiotensin-converting enzyme 2 overexpression improves central nitric oxide mediated sympathetic outflow in chronic heart failure. Am J Physiol Heart Circ Physiol 301: H2402-H2412, 2011.
55. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45: 717-723, 2005.